Ignite Creation Date:
2024-05-05 @ 10:05 PM
Last Modification Date:
2024-10-26 @ 10:13 AM
Study NCT ID:
NCT01029548
Status:
COMPLETED
Last Update Posted:
2016-03-04
First Post:
2009-12-09
Brief Title:
Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Sponsor:
Barbara Ensoli MD
Organization:
Istituto Superiore di Sanità
Study Overview
Official Title:
Observational Study With Additional Diagnostic Procedures on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ISS OBS T-003
Brief Summary:
The present study is designed as a prospective observational study directed at evaluating the frequency magnitude quality and persistence primary endpoint of the anti-Tat immune response in HIV-1 infected asymptomatic individuals and to prospectively evaluate the immunological virological and clinical outcome of anti-Tat positive versus anti-Tat negative drug naїve subjects secondary endpoint in order to determine the impact of anti-Tat immunity on HIV disease progression as well as the potential use of anti-Tat immune response assessment for the clinical and therapeutic management of infected patients This survey provided important information for the design planning and conduction of future therapeutic vaccine trials based on the HIV-1 Tat protein in asymptomatic subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None